Artificial intelligence
Guiding global pioneers to harness AI responsibly and unlock its enormous potential
We are deeply engaged in the global conversation on AI and its impact, and are active with leaders from academia, business, regulators and government.
Our central role in this discourse means we are perfectly positioned to advise clients in any sector. Whatever your industry, our team of over 150 technology lawyers – based in Silicon Valley, and tech hubs across the US, UK, Europe and Asia – delivers tailored advice grounded in applied knowledge. We take a fully integrated approach to AI-related matters, with cross-disciplinary experts across every field of legal expertise working together to address every angle.
Our clients range from multinational tech companies and blue-chip businesses to emerging startups that are instrumental in shaping the AI landscape. We guide these organizations on their most strategic, sensitive and high-profile projects. We regularly advise on AI governance and compliance strategies, high-risk AI use cases and tech regulatory and data privacy issues.
We keep you updated on how different legal areas intersect as you develop and deploy AI, and we stay ahead of market trends to ensure you do, too. Our AI practice unites specialists across all our practice areas, giving you comprehensive support for every opportunity and obstacle.
AI is revolutionizing business around the world. Whether you are developing the next language model or integrating AI into your enterprise, Freshfields provides tailored legal guidance to help you capitalize on opportunities and minimize risks.
Recent client successes include:
Advising on LSEG’s groundbreaking 10-year strategic partnership with Microsoft for their next generation AI and cloud infrastructure solution.
As a result of our work, Freshfields was recognized as (i) The Lawyer Corporate Team of the Year (ii) Financial Times Innovative Lawyer Europe Awards – Technology Category and (iii) Legal Business Awards Corporate Team of the Year.
Representing a leading AI company in inquiries by a US federal consumer protection regulator and a State Attorney General regarding its Generative AI products.
Engaging with the data protection regulators in the EU, and advising on the implications of the AI Act, in relation to various AI use cases to facilitate the processing of health insurance claims.
Providing strategic advice to a leading biotech company with respect to a potential licensing and collaboration arrangement with a Fortune 100 company for the use of their AI/ML protein design platform for drug development.
Advised Axel Springer (Politico, Business Insider, Bild and Welt) on the IP and commercial aspects of its global partnership with OpenAI.
Awards and Recognitions
- Global Market Leader Artificial Intelligence, Chambers Global Guide 2025
- Most Digital Law Firm, Financial Times
- Innovative Lawyers in Technology, Financial Times
